Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Cannabis

Apollon Formularies appoints joint COOs

Stephen Barnhill Jr will focus his attentions on Jamaica, the Caribbean and North America, while Stene Jacobs will focus on Apollon’s operations across Europe and Africa

Apollon Formularies PLC (LON:APOL) said it appointed Stephen Barnhill Jr and Stene Jacobs as joint chief operating officers in non-main board roles.

The pharmaceuticals firm said Barnhill Jr, who was a co-founder and president of Apollon Formularies Inc in the US, will focus his attentions on Jamaica, the Caribbean and North America, while Jacobs will focus on Apollon’s operations across Europe and Africa.

READ: Apollon Formularies cannabis formulations show early promise in prostate cancer

Jacobs joined Apollon in December 2020 as head of corporate development after previously co-founding Eyecom LED Solutions, a provider of premier specialist LED technology on the African continent.

"We are pleased to bring these exceptional people, who have both been pivotal in Apollon's success thus far, onto our executive management team. Apollon's strategy for growth is something we are giving a lot of attention to and utilising the skills and experience that Stephen and Stene possess, I am confident that we will start to see significant global expansion and revenue generation", Apollon chief executive Stephen Barnhill said in a statement.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK